Publications by authors named "Mahasti Bert"

Claim this Profile
N
Nivolumab added to cisplatin and radiotherapy versus cisplatin and radiotherapy alone after surgery for people with squamous cell carcinoma of the head and neck at a high risk of relapse (GORTEC 2018-01 NIVOPOST-OP): a randomised, open-label, phase 3 trial.
Jean Bourhis, Anne Aupérin, Christian Borel, Gautier Lefebvre, Severine Racadot, Mahasti Bert

Lancet· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis